56.72% of Mangoceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Mangoceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company	Details
8/8/2023	Colonial River Wealth Management LLC	36,100	$66K	0.0%	N/A	0.216%
7/28/2023	Independent Advisor Alliance	26,000	$48K	0.0%	N/A	0.162%

Data available starting January 2016

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Today's Range

Now: $0.30

$0.30

$0.32

50 Day Range

MA: $0.33

$0.22

$0.52

52 Week Range

Now: $0.30

$0.14

$1.95

Volume

199,572 shs

Average Volume

1,656,208 shs

Market Capitalization

$7.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.13

Who are the company insiders with the largest holdings of Mangoceuticals?: Mangoceuticals' top insider shareholders include:
Jacob D Cohen (CEO)
Alex P Hamilton (Director)
Learn More about top insider investors at Mangoceuticals.